Hinova Pharmaceuticals Inc. (SHA:688302)
China
· Delayed Price · Currency is CNY 50.86
+1.66 (3.37%)
At close: Jul 4, 2025, 2:57 PM CST
Hinova Pharmaceuticals Revenue
Hinova Pharmaceuticals had revenue of 366.84K CNY in the twelve months ending March 31, 2025. In the year 2024, Hinova Pharmaceuticals had annual revenue of 366.84K.
Revenue
366.84K
Revenue Growth
n/a
P/S Ratio
13,728.02
Revenue / Employee
2.11K
Employees
174
Market Cap
5.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |